139 related articles for article (PubMed ID: 1305049)
1. Chelidonium majus L. (Ukrain) in the treatment of cancer patients.
Lohninger A; Hamler F
Drugs Exp Clin Res; 1992; 18 Suppl():73-7. PubMed ID: 1305049
[TBL] [Abstract][Full Text] [Related]
2. Preliminary studies on the effect of Ukrain (Tris(2-([5bS-(5ba,6b,12ba)]- 5b,6,7,12b,13,14-hexahydro-13-methyl[1,3] benzodioxolo[5,6-v]-1-3- dioxolo[4,5-i]phenanthridinium-6-ol]-Ethaneaminyl)Phosphinesulfide.6HCl ) on the immunological response in patients with malignant tumours.
Danilos J; Zbroja-Sontag W; Baran E; Kurylcio L; Kondratowicz L; Jusiak L
Drugs Exp Clin Res; 1992; 18 Suppl():55-62. PubMed ID: 1305046
[TBL] [Abstract][Full Text] [Related]
3. Ukrain both as an anti cancer and immunoregulatory agent.
Nowicky JW; Manolakis G; Meijer D; Vatanasapt V; Brzosko WJ
Drugs Exp Clin Res; 1992; 18 Suppl():51-4. PubMed ID: 1305045
[TBL] [Abstract][Full Text] [Related]
4. Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation.
Cordes N; Plasswilm L; Bamberg M; Rodemann HP
Int J Radiat Biol; 2002 Jan; 78(1):17-27. PubMed ID: 11747550
[TBL] [Abstract][Full Text] [Related]
5. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.
Habermehl D; Kammerer B; Handrick R; Eldh T; Gruber C; Cordes N; Daniel PT; Plasswilm L; Bamberg M; Belka C; Jendrossek V
BMC Cancer; 2006 Jan; 6():14. PubMed ID: 16417634
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of different doses of Ukrain in the combined treatment of breast cancer.
Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Brzosko WJ
Drugs Exp Clin Res; 2000; 26(5-6):201-21. PubMed ID: 11345028
[TBL] [Abstract][Full Text] [Related]
7. Ukrain therapy in a frontal anaplastic grade III astrocytoma (case report).
Steinacker J; Kroiss T; Korsh OB; Melnyk A
Drugs Exp Clin Res; 1996; 22(3-5):275-7. PubMed ID: 8899347
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid alkaloid derivatives from Chelidonium majus L. (Ukrain).
Staniszewski A; Slesak B; Kołodziej J; Harłozińska-Szmyrka A; Nowicky JW
Drugs Exp Clin Res; 1992; 18 Suppl():63-7. PubMed ID: 1305047
[TBL] [Abstract][Full Text] [Related]
9. The effects of thiophosphoric acid (Ukrain) on cervical cancer, stage IB bulky.
Pengsaa P; Wongpratoom W; Vatanasapt V; Udomthavornsuk B; Mairieng E; Tangvorapongchai V; Pesi M; Krusan S; Boonvisoot V; Nowicky JW
Drugs Exp Clin Res; 1992; 18 Suppl():69-72. PubMed ID: 1305048
[TBL] [Abstract][Full Text] [Related]
10. Ukrain: a novel antitumor drug.
Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Nowicky JW; Volchek IV; Brzosko WJ; Hodysh YJ
Drugs Exp Clin Res; 2000; 26(5-6):341-56. PubMed ID: 11345050
[TBL] [Abstract][Full Text] [Related]
11. Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain.
Uglyanitsa KN; Nefyodov LI; Karayedova LM; Nowicky JW; Brzosko W
Drugs Exp Clin Res; 2000; 26(5-6):239-47. PubMed ID: 11345031
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of thiophosphoric acid alkaloid derivatives from Chelidonium majus L. ("Ukrain") as an immunostimulant in patients with various carcinomas.
Nowicky JW; Staniszewski A; Zbroja-Sontag W; Slesak B; Nowicky W; Hiesmayr W
Drugs Exp Clin Res; 1991; 17(2):139-43. PubMed ID: 1713821
[TBL] [Abstract][Full Text] [Related]
13. Chemical analyses of Ukrain, a semi-synthetic Chelidonium majus alkaloid derivative, fail to confirm its trimeric structure.
Panzer A; Joubert AM; Eloff JN; Albrecht CF; Erasmus E; Seegers JC
Cancer Lett; 2000 Nov; 160(2):237-41. PubMed ID: 11053654
[TBL] [Abstract][Full Text] [Related]
14. Ukrain treatment in a patient with breast carcinoma. Case report.
Zemskov SV; Prokopchuk OL; Susak YM
Drugs Exp Clin Res; 2000; 26(5-6):253-4. PubMed ID: 11345033
[TBL] [Abstract][Full Text] [Related]
15. In-vitro toxicity of Ukrain against human Ewing tumor cell lines.
Lanvers-Kaminsky C; Nolting DM; Köster J; Schröder A; Sandkötter J; Boos J
Anticancer Drugs; 2006 Oct; 17(9):1025-30. PubMed ID: 17001175
[TBL] [Abstract][Full Text] [Related]
16. Results of Ukrain monotherapy of prostate cancer.
Uglyanitsa KN; Nechiporenko NA; Nefyodov LI; Doroshenko YM; Brzosko W; Nowicky W
Drugs Exp Clin Res; 2000; 26(5-6):191-3. PubMed ID: 11345026
[TBL] [Abstract][Full Text] [Related]
17. Potential therapeutic efficacy of Ukrain (NSC 631570) in AIDS patients with Kaposi's sarcoma.
Voltchek IV; Liepins A; Nowicky JW; Brzosko WJ
Drugs Exp Clin Res; 1996; 22(3-5):283-6. PubMed ID: 8899349
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo investigations on the antitumour activity of Chelidonium majus.
Capistrano I R; Wouters A; Lardon F; Gravekamp C; Apers S; Pieters L
Phytomedicine; 2015 Dec; 22(14):1279-87. PubMed ID: 26626193
[TBL] [Abstract][Full Text] [Related]
19. Ukrain treatment of a patient with retroperitoneal synovial sarcoma. Case report.
Prokopchuk OL; Zemskov SV; Susak YM
Drugs Exp Clin Res; 2000; 26(5-6):255-6. PubMed ID: 11345034
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies.
Sotomayor EM; Rao K; Lopez DM; Liepins A
Drugs Exp Clin Res; 1992; 18 Suppl():5-11. PubMed ID: 1305044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
